000 | 01966 a2200589 4500 | ||
---|---|---|---|
005 | 20250517173138.0 | ||
264 | 0 | _c20180626 | |
008 | 201806s 0 0 eng d | ||
022 | _a1098-6596 | ||
024 | 7 |
_a10.1128/AAC.00969-17 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKidwai, Saqib | |
245 | 0 | 0 |
_aDual Mechanism of Action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _c11 2017 |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 |
_aAutophagy _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMacrophages _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aMycobacterium bovis _xdrug effects |
650 | 0 | 4 |
_aMycobacterium smegmatis _xdrug effects |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aNitroimidazoles _xpharmacology |
650 | 0 | 4 |
_aPhenanthrolines _xpharmacology |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTHP-1 Cells |
650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
700 | 1 | _aPark, Chan-Yong | |
700 | 1 | _aMawatwal, Shradha | |
700 | 1 | _aTiwari, Prabhakar | |
700 | 1 | _aJung, Myung Geun | |
700 | 1 | _aGosain, Tannu Priya | |
700 | 1 | _aKumar, Pradeep | |
700 | 1 | _aAlland, David | |
700 | 1 | _aKumar, Sandeep | |
700 | 1 | _aBajaj, Avinash | |
700 | 1 | _aHwang, Yun-Kyung | |
700 | 1 | _aSong, Chang Sik | |
700 | 1 | _aDhiman, Rohan | |
700 | 1 | _aLee, Ill Young | |
700 | 1 | _aSingh, Ramandeep | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 61 _gno. 11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00969-17 _zAvailable from publisher's website |
999 |
_c27548849 _d27548849 |